Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA)

被引：8
|
作者：
Cerchione, Claudio [1 ]
Catalano, Lucio [1 ]
Cerciello, Giuseppe [1 ]
Avilia, Simona [1 ]
Picardi, Marco [1 ]
Risitano, Antonio Maria [1 ]
Pisano, Ida [1 ]
Alfinito, Fiorella [1 ]
Pane, Fabrizio [1 ]
机构：
[1] AOU Federico II, Naples, Italy
来源：
ANNALS OF HEMATOLOGY | 2015年 / 94卷 / 03期
关键词：
Lenalidomide; Myelodysplastic Syndrome; Acute Myeloid Leukaemia; Alemtuzumab; Erythroid Precursor;
D O I：
10.1007/s00277-014-2192-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：531 / 534
页数：4
相关论文
共 50 条
  • [1] Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA)
    Claudio Cerchione
    Lucio Catalano
    Giuseppe Cerciello
    Simona Avilia
    Marco Picardi
    Antonio Maria Risitano
    Ida Pisano
    Fiorella Alfinito
    Fabrizio Pane
    Annals of Hematology, 2015, 94 : 531 - 534
  • [2] ROLE OF LENALIDOMIDE IN MANAGEMENT OF MYELODYSPLASTIC SYNDROMES (MDS) WITH DEL(5Q) ASSOCIATED WITH PURE RED CELL APLASIA (PRCA)
    Cerchione, C.
    Cerciello, G.
    Della Pepa, R.
    Pugliese, N.
    Marano, L.
    Vitagliano, O.
    Luciano, L.
    Alfinito, F.
    Pane, F.
    Risitano, A.
    HAEMATOLOGICA, 2013, 98 : 691 - 692
  • [3] Role of lenalidomide in management of pure red cell aplasia (PRCA) and myelodysplastic syndromes (MDS) with del(5q)
    Cerchione, C.
    Cerciello, G.
    Della Pepa, R.
    Pugliese, N.
    Marano, L.
    Vitagliano, O.
    Luciano, L.
    Alfinito, F.
    Pane, F.
    Risitano, A. M.
    LEUKEMIA RESEARCH, 2013, 37 : S100 - S100
  • [4] Del(5q) myelodysplastic syndrome combined with pure red cell aplasia
    Park, Joowon
    BLOOD RESEARCH, 2018, 53 (02) : 104 - 104
  • [5] Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
    Giagounidis, Aristoteles A. N.
    SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 312 - 322
  • [6] Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond
    Talati, Chetasi
    Sallman, David
    List, Alan
    SEMINARS IN HEMATOLOGY, 2017, 54 (03) : 159 - 166
  • [7] MOLECULAR MECHANISMS OF LENALIDOMIDE RESISTANCE IN DEL(5Q) MYELODYSPLASTIC SYNDROMES
    Martinez-Hoyer, Sergio
    Deng, Yu
    Parker, Jeremy
    Jiang, Jihong
    Docking, Roderick
    Mo, Angela
    Gharaee, Nadia
    Jadersten, Martin
    Kulasekararaj, Austin
    Malcovati, Luca
    List, Alan
    Hellstrom-Lindberg, Eva
    Platzbecker, Uwe
    Karsan, Aly
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S72 - S72
  • [8] Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
    Mahmoud R. Gaballa
    Emmanuel C. Besa
    Annals of Hematology, 2014, 93 : 723 - 733
  • [9] Pure red cell aplasia associated with myelodysplastic syndromes
    Park, S
    Merlat, A
    Guesnu, M
    Picard, F
    Viguié, F
    Vassilieff, D
    Dreyfus, F
    LEUKEMIA, 2000, 14 (09) : 1709 - 1710
  • [10] Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
    Gaballa, Mahmoud R.
    Besa, Emmanuel C.
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 723 - 733
12345